These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27847614)

  • 1. Metamizole versus placebo for panretinal photocoagulation pain control: a prospective double-masked randomized controlled study.
    de Araújo RB; Zacharias LC; de Azevedo BM; Giusti BS; Pretti RC; Takahashi WY; Monteiro MLR
    Int J Retina Vitreous; 2015; 1():21. PubMed ID: 27847614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral versus topical diclofenac for pain prevention during panretinal photocoagulation.
    Zakrzewski PA; O'Donnell HL; Lam WC
    Ophthalmology; 2009 Jun; 116(6):1168-74. PubMed ID: 19376588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-Emptive Topical Ketorolac Tromethamine 0.5% for Panretinal Photocoagulation.
    Chewa Raja JS; Singh S; Ismail F
    J Ocul Pharmacol Ther; 2021 Jun; 37(5):313-317. PubMed ID: 33794664
    [No Abstract]   [Full Text] [Related]  

  • 4. Panretinal photocoagulation versus intravitreal injection retreatment pain in high-risk proliferative diabetic retinopathy.
    Lucena CR; Ramos Filho JA; Messias AM; Silva JA; Almeida FP; Scott IU; Ribeiro JA; Jorge R
    Arq Bras Oftalmol; 2013; 76(1):18-20. PubMed ID: 23812521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy.
    Zhou AY; Zhou CJ; Yao J; Quan YL; Ren BC; Wang JM
    Int J Ophthalmol; 2016; 9(12):1772-1778. PubMed ID: 28003978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
    JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pain scores between patients undergoing panretinal photocoagulation using navigated or pattern scan laser systems.
    Inan UU; Polat O; Inan S; Yigit S; Baysal Z
    Arq Bras Oftalmol; 2016 Feb; 79(1):15-8. PubMed ID: 26840160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Comfort with Yellow (577 nm) vs. Green (532 nm) Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy.
    Adam MK; Weinstock BM; Kasi SK; Ehmann DS; Hsu J; Garg SJ; Ho AC; Chiang A
    Ophthalmol Retina; 2018 Feb; 2(2):91-95. PubMed ID: 31047351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
    Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
    JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic effects of tramadol during panretinal photocoagulation.
    Ko BW; Shim JH; Lee BR; Cho HY
    Korean J Ophthalmol; 2009 Dec; 23(4):273-6. PubMed ID: 20046687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
    Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
    Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
    Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Spot Yellow Laser Versus Conventional Green Laser on Panretinal Photocoagulation: Patient Pain Scores and Preferences.
    González-Saldivar G; Rojas-Juárez S; Espinosa-Soto I; Sánchez-Ramos J; Jaurieta-Hinojosa N; Ramírez-Estudillo A
    Ophthalmic Surg Lasers Imaging Retina; 2017 Nov; 48(11):902-905. PubMed ID: 29121359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.
    Preti RC; Ramirez LM; Monteiro ML; Carra MK; Pelayes DE; Takahashi WY
    Br J Ophthalmol; 2013 Jul; 97(7):885-9. PubMed ID: 23686001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    ; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
    JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy.
    Sameen M; Khan MS; Mukhtar A; Yaqub MA; Ishaq M
    Pak J Med Sci; 2017; 33(1):142-145. PubMed ID: 28367188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double masked randomised controlled trial to assess the effectiveness of paracetamol in reducing pain in panretinal photocoagulation.
    Vaideanu D; Taylor P; McAndrew P; Hildreth A; Deady JP; Steel DH
    Br J Ophthalmol; 2006 Jun; 90(6):713-7. PubMed ID: 16421186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.